IPM Take
The 10,000-step target has become one of public health’s most successful numbers. Biology, however, does not appear to work according to a round number on a smartwatch.
A new British Journal of Sports Medicine analysis suggests that step volume and stepping intensity may offer different routes toward lower mortality risk. Among people taking fewer than 5,000 steps per day, a peak cadence of around 80 steps per minute was associated with a 28% lower all-cause mortality risk compared with the study reference group. A broadly similar risk reduction was observed among people walking 5,000 to 7,500 steps but at a lower cadence of around 60 steps per minute.
The lowest mortality risk overall was still seen among participants accumulating roughly 7,500 to 10,000 steps a day, so the study does not show that pace makes step count irrelevant. It suggests something more useful: there may be more than one way to accumulate protective physical activity.
That could matter for people with limited time, physical constraints or environments that make long periods of walking difficult. Prevention becomes more realistic when it offers several achievable routes rather than one pass-or-fail target.
Executive Summary
The prospective study used accelerometer data from 103,684 middle-aged UK Biobank participants who wore a wrist device for seven consecutive days between 2013 and 2015. Researchers examined both total daily steps and peak 30-minute cadence, defined as the average number of steps per minute during the participant’s 30 most active minutes of the day. Importantly, those 30 minutes did not need to occur consecutively.
Participants were divided into four daily step categories: fewer than 5,000, 5,000 to 7,500, 7,500 to 10,000 and more than 10,000 steps. The all-cause mortality analysis included 64,743 participants, with 1,697 deaths during approximately eight years of follow-up. The cardiovascular mortality analysis included 70,075 participants and recorded 502 cardiovascular deaths.
Among participants walking fewer than 5,000 steps daily, a peak cadence of 80 steps per minute was associated with an adjusted hazard ratio for all-cause mortality of 0.72, compared with the study reference. Among those walking 5,000 to 7,500 steps, a cadence of 60 steps per minute produced a similar hazard ratio of 0.70.
The lowest estimated all-cause mortality risk was observed in the 7,500 to 10,000 step group at a peak cadence of approximately 100 steps per minute, with a hazard ratio of 0.57. Cardiovascular mortality showed broadly similar patterns.
These results describe associations. They do not prove that increasing cadence or reaching a particular step threshold causes a specific reduction in mortality.
Why it matters
- HTA bodies: Wearables and digital prevention programmes increasingly use step targets as endpoints. These findings suggest that evaluating physical-activity interventions solely by total steps may miss meaningful differences in intensity and may need to account for how movement is accumulated.
- Payers: Flexible activity prescriptions could make prevention programmes more realistic for people unable to reach high daily step counts. However, reimbursement for digital or behavioural interventions should still depend on demonstrated changes in sustained activity and clinical outcomes, not simply hitting wearable-generated metrics.
- Industry / innovation partners: Wearable platforms already measure cadence, activity intensity and daily movement patterns. The opportunity is to move beyond generic 10,000-step goals toward more individualised activity targets, but algorithms will need prospective validation before they can credibly claim personalised cardiovascular prevention.
Ten thousand steps has become shorthand for a healthy day.
The new study does not say that target is wrong. It suggests that cardiovascular prevention may have been asking too simple a question.
Researchers examined two dimensions of walking simultaneously: how many steps people accumulated and how intensively they stepped. What emerged was not one ideal number, but several combinations associated with lower mortality.
For sedentary participants in particular, pace appeared to matter. People taking fewer than 5,000 daily steps had progressively lower mortality risk as peak cadence increased. Their estimated risk at around 80 steps per minute was comparable with participants who accumulated substantially more steps but moved at a lower intensity.
That offers a potentially useful message for cardiometabolic prevention.
Public-health advice often fails because the target appears unreachable. Someone accumulating 3,000 or 4,000 steps a day because of disability, work, caregiving or environmental constraints may see 10,000 as an entirely different lifestyle rather than an incremental goal.
A strategy that says “move more when possible, and make some of that movement more purposeful” may be more achievable.
The study does not make 10,000 steps obsolete
The opposite interpretation would also be a mistake.
The lowest estimated mortality risk remained in people accumulating approximately 7,500 to 10,000 steps each day, and higher volume continued to matter. The study therefore supports a trade-off between pace and volume, not the idea that a short brisk walk completely replaces daily movement.
There is also a technical distinction that matters.
The study measured “peak 30 cadence,” meaning the average cadence across the 30 highest stepping minutes during the day. Those minutes were not necessarily consecutive. It therefore does not prove that everyone should complete one continuous 30-minute walk at a prescribed pace.
Nor does an 80-step-per-minute threshold represent a universal biological prescription.
Participants were predominantly middle-aged and older adults in UK Biobank, movement was measured for only seven days, and healthier people may both walk more vigorously and live longer for reasons that statistical adjustment cannot completely remove. The authors explicitly classify the evidence as observational.
The access question goes beyond personal motivation
The study also deserves a policy interpretation.
Telling people to walk more assumes that everyone has equal access to safe pavements, parks, time, mobility and neighbourhoods designed around walking rather than cars.
They do not.
This becomes important if prevention moves toward increasingly personalised movement prescriptions. A recommendation to increase cadence is inexpensive on paper, but an individual’s capacity to act on it still depends on work schedules, disability, caregiving responsibilities, transport and the built environment.
That makes physical activity partly a behavioural risk and partly an access issue.
The most useful message from the study is therefore not that everyone should throw away the 10,000-step goal.
It is that cardiovascular prevention does not have to be binary.
More steps remain valuable, but for people unable to accumulate large volumes of walking, increasing the intensity of some of the steps they already take may offer another realistic pathway toward better health.
Precision prevention sometimes means finding a better drug or biomarker.
Sometimes it means giving people a target they can actually reach.
